You have read all your free articles, to continue reading subscribe to read the rest of this content.
Novo Nordisk announced results from a phase 2 clinical trial of investigational insulin icodec, a once-weekly basal insulin analogue. In the trial, adults with type 2 diabetes randomised to once-weekly insulin icodec achieved similar blood sugar control and a similar safety profile compared with Already a subscriber Login You have…
Ultimovacs has announced that the first patient has been enrolled in the DOVACC (Durvalumab Olaparib VACCine) study, a randomized Phase II clinical trial assessing the impact of the Company’s telomerase vaccine, UV1, on the standard of maintenance care in ovarian cancer. DOVACC is organized wAlready a subscriber Login You have…
The NEFIGAN Trial of Pharmalink AB’s Nefecon®, a drug for the treatment of primary IgA nephropathy, was stopped early because the drug fully met its primary efficacy endpoint at a planned interim analysis, according to news from BioSpace.com. The interim analysis, conducted by the Data &Already a subscriber Login You…
Interim results from the second dose group in the company's ongoing clinical phase I study SPAGOPIX-01 show that SpagoPix (SN132D) is well tolerated and provides clear contrast enhancement in MRI images of solid tumors in the breast, as well as in the pancreas and liver. Based on the results, theAlready…
